Peak Pharmaceuticals (OTCMKTS:PKPH) Stock Price Up 9.9% – Time to Buy?

Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report) shot up 9.9% during mid-day trading on Wednesday . The company traded as high as $1.00 and last traded at $1.00. Approximately 231 shares traded hands during trading, a decline of 97% from the average daily volume of 9,053 shares. The stock had previously closed at $0.91.

Peak Pharmaceuticals Price Performance

The company’s 50 day moving average is $0.89 and its 200 day moving average is $1.50.

About Peak Pharmaceuticals

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Featured Stories

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.